{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:56:32Z","timestamp":1781142992844,"version":"3.54.1"},"reference-count":55,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Multiple sclerosis (MS) is an autoimmune neuroinflammatory disease affecting 2.9 million worldwide. Current immunosuppressive treatments offer limited neuroprotection and often cause adverse effects. Polyphenols with antioxidant and anti-inflammatory properties have been investigated as adjuncts in MS. Methods: On 19 June 2025, Embase, Medline, and ClinicalTrials.gov were systematically searched. Eligible clinical trials assessing polyphenol supplementation in MS were included. Outcomes of interest were Expanded Disability Status Scale (EDSS), annualised relapse rate (ARR), magnetic resonance imaging (MRI) changes, safety, and tolerability. Risk of bias was evaluated using the Cochrane tool, and certainty of evidence was appraised with Grading of Recommendations Assessment, Development, and Evaluation (GRADE). The protocol was registered with PROSPERO (CRD420251052042). Results: Of 870 records identified, 13 trials (n = 785) met inclusion. Nanocurcumin consistently improved EDSS in relapsing\u2013remitting MS (3 trials, n = 150; p = 0.039\u20130.041), while epigallocatechin-3-gallate, silymarin (SM), cranberry extract, and bio-enhanced curcumin extract (BCM-95) curcumin showed no significant impact on disability, relapse rates, or MRI outcomes. Intervention adverse events were generally mild. SM showed potential hepatoprotective effects. Risk of bias was determined as low risk for seven of the trials and of some concern for five of the studies. Most often raising concerns because of selective reporting. Certainty of evidence, assessed using GRADE, was generally moderate, indicating some uncertainty regarding the outcomes. Meta-analysis was not possible due to the heterogeneity of included studies. Conclusions: Nanocurcumin may contribute to improvements in disability outcomes in Relapse Remitting Multiple Sclerosis (RRMS), whereas other polyphenols lack consistent efficacy. However, the evidence base remains limited by small sample sizes and methodological concerns. Larger, multicentre randomised controlled trials are required to establish optimal dosing, long-term safety, and therapeutic potential.<\/jats:p>","DOI":"10.3390\/nu18121875","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:48:35Z","timestamp":1781138915000},"page":"1875","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Polyphenol Supplementation in People with Multiple Sclerosis: A Systematic Review of Clinical Trials"],"prefix":"10.3390","volume":"18","author":[{"given":"Lauren","family":"Brooks","sequence":"first","affiliation":[{"name":"School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK"},{"name":"North Bristol NHS Trust, Southmead Hospital, Bristol BS10 5NB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9300-9350","authenticated-orcid":false,"given":"Aqif Farhan bin Azmil","family":"Farid","sequence":"additional","affiliation":[{"name":"Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amudha","family":"Poobalan","sequence":"additional","affiliation":[{"name":"The Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, Foresterhill Campus, University of Aberdeen, Aberdeen AB25 2ZD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-292X","authenticated-orcid":false,"given":"Alexandra","family":"Johnstone","sequence":"additional","affiliation":[{"name":"The Rowett Institute, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill Health Campus, Ashgrove Road West, Aberdeen AB25 2ZD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3852-6158","authenticated-orcid":false,"given":"Phyo Kyaw","family":"Myint","sequence":"additional","affiliation":[{"name":"The Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, Foresterhill Campus, University of Aberdeen, Aberdeen AB25 2ZD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"ref_1","unstructured":"MS Trust (2024). How Common Is Multiple Sclerosis?, MS Trust. Available online: https:\/\/mstrust.org.uk\/information-support\/about-ms\/how-common-multiple-sclerosis."},{"key":"ref_2","unstructured":"National Institute for Health and Care Excellence (NICE) (2024). Multiple Sclerosis, NICE. Available online: https:\/\/cks.nice.org.uk\/topics\/multiple-sclerosis\/."},{"key":"ref_3","first-page":"e33187","article-title":"An overview of the history, pathophysiology, and pharmacological interventions of multiple sclerosis","volume":"15","author":"Dighriri","year":"2023","journal-title":"Cureus"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neurol.2018.03.006","article-title":"Progress in understanding the pathophysiology of multiple sclerosis","volume":"174","year":"2018","journal-title":"Rev. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e37297","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_7","unstructured":"MS Society (2026, March 25). Disease Modifying Therapies (DMTs). Available online: https:\/\/www.mssociety.org.uk\/living-with-ms\/treatments-and-therapies\/disease-modifying-therapies."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: A review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e14264","DOI":"10.1111\/jfbc.14264","article-title":"Health benefits of polyphenols: A concise review","volume":"46","author":"Rana","year":"2022","journal-title":"J. Food Biochem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Turiaco, F., Cullotta, C., Mannino, F., Bruno, A., Squadrito, F., Pallio, G., and Irrera, N. (2024). Attention deficit hyperactivity disorder (ADHD) and polyphenols: A systematic review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031536"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/NHA-240006","article-title":"Effect of polyphenols on inflammation related to cognitive function: A systematic review and meta-analysis of human randomized controlled trials","volume":"9","author":"Mekhora","year":"2024","journal-title":"Nutr. Healthy Aging"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Schuldesz, A.C., Radu, T., Nandarge, P.S., Elagez, A., Cornea, A., Ion, R., Bratosin, F., Prodan, M., and Simu, M. (2024). The effects of epigallocatechin-3-gallate nutritional supplementation in the management of multiple sclerosis: A systematic review of clinical trials. Nutrients, 16.","DOI":"10.3390\/nu16162723"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_16","unstructured":"GRADE Working Group (2026, January 06). GRADE Handbook. Available online: https:\/\/www.gradeworkinggroup.org\/."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int. J. Qual. Health Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2015.08.006","article-title":"Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic","volume":"358","author":"Louvera","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3945\/ajcn.113.075309","article-title":"Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis","volume":"101","author":"Steiniger","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_20","first-page":"e971","article-title":"Epigallocatechin gallate in progressive multiple sclerosis","volume":"8","author":"Rust","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103274","DOI":"10.1016\/j.msard.2021.103274","article-title":"Curcumin supplementation in active relapsing multiple sclerosis (CONTAIN)","volume":"56","author":"Petracca","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_22","first-page":"e22816","article-title":"Antioxidative effects of silymarin in fingolimod-treated RRMS patients","volume":"35","author":"Ghiasian","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e981","DOI":"10.1212\/NXI.0000000000000981","article-title":"Epigallocatechin gallate in relapsing-remitting multiple sclerosis","volume":"8","author":"Paul","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1002\/jcp.26301","article-title":"Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial","volume":"233","author":"Dolati","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jneuroim.2019.01.007","article-title":"Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial","volume":"327","author":"Dolati","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.pharep.2018.05.008","article-title":"Nanocurcumin as a novel therapy for multiple sclerosis","volume":"70","author":"Dolati","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1177\/1352458513517592","article-title":"Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: A multicenter, randomized, placebo-controlled, double-blind trial","volume":"20","author":"Gallien","year":"2014","journal-title":"Mult. Scler. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"107715","DOI":"10.1016\/j.intimp.2021.107715","article-title":"Immunomodulatory and hepatoprotective effects of silymarin in MS patients","volume":"97","author":"Abbasirad","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jnnp-2018-319496","article-title":"Flavonoid-rich cocoa for fatigue in multiple sclerosis","volume":"90","author":"Coe","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.intimp.2018.05.018","article-title":"Changes in Th17 cell function after nanocurcumin use","volume":"61","author":"Dolati","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_32","unstructured":"PRISMA (2025, November 30). PRISMA 2020 Flow Diagram. Available online: https:\/\/www.prisma-statement.org\/prisma-2020-flow-diagram."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1756285613488434","article-title":"Sex and gender issues in multiple sclerosis","volume":"6","author":"Harbo","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_34","first-page":"55","article-title":"Risk-of-bias visualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"11","author":"McGuinness","year":"2020","journal-title":"Res. Synth. Methods"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/rssa.12275","article-title":"A re-evaluation of fixed-effect meta-analysis","volume":"181","author":"Rice","year":"2018","journal-title":"J. R. Stat. Soc. Ser. A"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"La Rosa, G., Lonardo, M.S., Cacciapuoti, N., Muscariello, E., Guida, B., Faraonio, R., Santillo, M., and Damiano, S. (2023). Dietary polyphenols, microbiome, and multiple sclerosis: From molecular anti-inflammatory and neuroprotective mechanisms to clinical evidence. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087247"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s13105-025-01105-7","article-title":"Phenolic compounds and epigenetic mechanisms regulating gene expression: Effects on human health","volume":"81","author":"Costa","year":"2025","journal-title":"J. Physiol. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/j.biomaterials.2013.12.090","article-title":"Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment","volume":"35","author":"Naksuriya","year":"2014","journal-title":"Biomaterials"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fphar.2020.00487","article-title":"Nanocurcumin: A promising candidate for therapeutic applications","volume":"11","author":"Karthikeyan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"103144","DOI":"10.1016\/j.msard.2021.103144","article-title":"Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter- and intra-rater reliability","volume":"54","author":"Cohen","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_41","first-page":"S46","article-title":"Multiple Sclerosis Functional Composite (MSFC): Scoring instructions","volume":"55","year":"2018","journal-title":"Noro Psikiyatr. Ars."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105958","DOI":"10.1016\/j.jff.2023.105958","article-title":"Evaluation of the immunomodulatory, antioxidant, proliferative, and anti-apoptotic effects of nano-silymarin on mesenchymal stem cells isolated from multiple sclerosis patients\u2019 adipose tissue","volume":"113","author":"Yousefi","year":"2024","journal-title":"J. Funct. Foods"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/JMAU.JMAU_59_18","article-title":"Factors involved in relapse of multiple sclerosis","volume":"7","author":"Kamel","year":"2019","journal-title":"J. Microsc. Ultrastruct."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1001\/archneur.59.10.1572","article-title":"Longitudinal brain volume measurement in multiple sclerosis","volume":"59","author":"Kalkers","year":"2002","journal-title":"Arch. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1468-1331.2010.03093.x","article-title":"T2 lesions and rate of progression of disability in multiple sclerosis","volume":"17","author":"Mostert","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","article-title":"Hepatoprotective effect of silymarin","volume":"6","year":"2014","journal-title":"World J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10753-018-0872-x","article-title":"Immunoregulatory effects of silymarin on proliferation and activation of Th1 cells isolated from newly diagnosed and IFN-\u03b21b-treated MS patients","volume":"42","author":"Navabi","year":"2019","journal-title":"Inflammation"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Cai, Z.Y., Li, X.M., Liang, J.P., Xiang, L.P., Wang, K.R., Shi, Y.L., Yang, R., Shi, M., Ye, J.H., and Lu, J.L. (2018). Bioavailability of tea catechins and its improvement. Molecules, 23.","DOI":"10.3390\/molecules23092346"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajpath.2011.09.007","article-title":"Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets","volume":"180","author":"Wang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Andreu-Fern\u00e1ndez, V., Almeida Toledano, L., Pizarro Lozano, N., Navarro Tapia, E., Roig, M.D.G., de la Torre, F.R., and Algar, \u00d3.G. (2020). Bioavailability of epigallocatechin gallate administered with different nutritional strategies in healthy volunteers. Antioxidants, 9.","DOI":"10.3390\/antiox9050440"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1024120","DOI":"10.3389\/fimmu.2023.1024120","article-title":"Efficacy and safety of dietary polyphenols in rheumatoid arthritis: A systematic review and meta-analysis of 47 randomized controlled trials","volume":"14","author":"Long","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_52","first-page":"472","article-title":"The protective effects of polyphenols on Alzheimer\u2019s disease: A systematic review","volume":"4","author":"Colizzi","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"230S","DOI":"10.1093\/ajcn\/81.1.230S","article-title":"Bioavailability and bioefficacy of polyphenols in humans","volume":"81","author":"Manach","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano-based drug delivery systems: Recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"ref_55","unstructured":"Campbell Collaboration (2025, August 15). Practical Meta-Analysis Effect Size Calculator. Available online: https:\/\/www.campbellcollaboration.org\/calculator\/equations."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/12\/1875\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:57:13Z","timestamp":1781139433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/12\/1875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["nu18121875"],"URL":"https:\/\/doi.org\/10.3390\/nu18121875","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}